Evidence map›Paper›PMID 41694106›Full record

ArticleExperimental and therapeutic medicine2026

Comprehensive diagnosis and individualized treatment of multiple primary lung cancer: A case report.

Guoxiong Zeng, Yunyan Zhou, Wang Wan, Biao Deng, Chunyuan Chen, Zhu Liang

Abstract readCase Reports
In one paragraph

Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guoxiong ZengDepartment of Cardiothoracic Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510000, P.R. China.
Yunyan ZhouDepartment of Radiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510000, P.R. China.
Wang WanDepartment of Thoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524000, P.R. China.
Biao DengDepartment of Thoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524000, P.R. China.
Chunyuan ChenDepartment of Thoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524000, P.R. China.
Zhu LiangDepartment of Thoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the popularity of low-dose CT, the detection rate of multiple primary lung cancer (MPLC) has gradually increased. However, to the best of our knowledge, no unified standard for diagnosing MPLC currently exists. Therefore, the differentiation of this tumor type from lung cancer intrapulmonary metastasis (IM) can aid the diagnosis of MPLC. The treatment strategies and prognosis of these two tumor types are different. The present report documents the case of a 45-year-old female patient with MPLC with >20 lesions in both lungs. Enhanced chest CT imaging indicated IM, prompting admission to the hospital for clarification of the pathology of the lung lesions and for receiving drug therapy. However, whole-body PET-CT revealed an anterior left upper lobe lesion with increased F

Indexed as

diagnosismolecular detectionMPLCnext-generation sequencingtreatment

Identifiers

PMID41694106
PMCPMC12902764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.